These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25150583)

  • 1. Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features.
    Gu J; Tao J; Yang X; Li P; Yang X; Qin C; Cao Q; Cai H; Zhang Z; Wang M; Gu M; Lu Q; Yin C
    Cancer Genet; 2014 Jun; 207(6):247-52. PubMed ID: 25150583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.
    Ashokkumar M; Anbarasan C; Saibabu R; Kuram S; Raman SC; Cherian KM
    Thromb Res; 2011 Oct; 128(4):e49-53. PubMed ID: 21762961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.
    Timirci-Kahraman O; Ozkan NE; Turan S; Farooqi AA; Verim L; Ozturk T; Inal-Gultekin G; Isbir T; Ozturk O; Yaylim I
    Genet Test Mol Biomarkers; 2015 Jun; 19(6):309-15. PubMed ID: 25955868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c.29C>T polymorphism in the transforming growth factor-β1 (TGFB1) gene correlates with increased risk of urinary bladder cancer.
    Gautam KA; Pooja S; Sankhwar SN; Sankhwar PL; Goel A; Rajender S
    Cytokine; 2015 Oct; 75(2):344-8. PubMed ID: 26048435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stem cell antigen rs2294008 (C>T) polymorphism and bladder cancer risk: a meta-analysis based on cases and controls.
    Zhao Y; Gui ZL; Liao S; Gao F; Ge YZ; Jia RP
    Genet Mol Res; 2014 Jul; 13(3):5534-40. PubMed ID: 25117309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
    Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
    Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
    Safarinejad MR; Shafiei N; Safarinejad SH
    Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
    Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
    BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
    Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W
    Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
    Liu J; Yang XM; Liu G; Chang LS; Zhang LR; Song DK
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3122-5. PubMed ID: 20193274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
    Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
    In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases.
    Amasyali AS; Kucukgergin C; Erdem S; Sanli O; Seckin S; Nane I
    J Urol; 2012 Dec; 188(6):2398-403. PubMed ID: 23088972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?
    Gangwar R; Ahirwar D; Mandhani A; Mittal RD
    Mutat Res; 2009; 680(1-2):56-63. PubMed ID: 19815090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Rasool R; Afroze D; Yousuf A; Wani S; Siddiqi M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):263-8. PubMed ID: 21156242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HRAS T81C polymorphism modulates risk of urinary bladder cancer and predicts advanced tumors in ethnic Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Baba KM; Wani MS; Siddiqi MA
    Urol Oncol; 2013 May; 31(4):487-92. PubMed ID: 21514184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence.
    Koch W; Hoppmann P; de Waha A; Schömig A; Kastrati A
    Hum Mol Genet; 2008 Apr; 17(8):1120-6. PubMed ID: 18178577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.